1. Home
  2. OABI vs RYAM Comparison

OABI vs RYAM Comparison

Compare OABI & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OABI
  • RYAM
  • Stock Information
  • Founded
  • OABI 2012
  • RYAM 1926
  • Country
  • OABI United States
  • RYAM United States
  • Employees
  • OABI 114
  • RYAM N/A
  • Industry
  • OABI Biotechnology: Pharmaceutical Preparations
  • RYAM Paper
  • Sector
  • OABI Health Care
  • RYAM Basic Materials
  • Exchange
  • OABI Nasdaq
  • RYAM Nasdaq
  • Market Cap
  • OABI 228.9M
  • RYAM 255.7M
  • IPO Year
  • OABI N/A
  • RYAM N/A
  • Fundamental
  • Price
  • OABI $1.57
  • RYAM $5.99
  • Analyst Decision
  • OABI Strong Buy
  • RYAM Buy
  • Analyst Count
  • OABI 3
  • RYAM 1
  • Target Price
  • OABI $6.67
  • RYAM $6.00
  • AVG Volume (30 Days)
  • OABI 385.0K
  • RYAM 752.4K
  • Earning Date
  • OABI 08-06-2025
  • RYAM 11-04-2025
  • Dividend Yield
  • OABI N/A
  • RYAM N/A
  • EPS Growth
  • OABI N/A
  • RYAM N/A
  • EPS
  • OABI N/A
  • RYAM N/A
  • Revenue
  • OABI $23,027,000.00
  • RYAM $1,519,622,000.00
  • Revenue This Year
  • OABI N/A
  • RYAM N/A
  • Revenue Next Year
  • OABI $44.99
  • RYAM $4.65
  • P/E Ratio
  • OABI N/A
  • RYAM N/A
  • Revenue Growth
  • OABI 6.05
  • RYAM N/A
  • 52 Week Low
  • OABI $1.22
  • RYAM $3.35
  • 52 Week High
  • OABI $4.87
  • RYAM $10.28
  • Technical
  • Relative Strength Index (RSI)
  • OABI 38.28
  • RYAM 74.74
  • Support Level
  • OABI $1.51
  • RYAM $5.50
  • Resistance Level
  • OABI $1.73
  • RYAM $6.07
  • Average True Range (ATR)
  • OABI 0.12
  • RYAM 0.25
  • MACD
  • OABI -0.01
  • RYAM 0.04
  • Stochastic Oscillator
  • OABI 11.32
  • RYAM 92.61

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: